Lilly Announces the Institute for Genetic Medicine and $700 Million investment in Boston Seaport Site
INDIANAPOLIS, Feb. 22, 2022 /PRNewswire/ — Eli Lilly and Company (NYSE: LLY) today announced the launch of the Lilly Institute for Genetic Medicine and an investment of approximately $700 million to establish a state-of-the-art facility at a new site in the Boston Seaport. This…
Comments Off on Lilly Announces the Institute for Genetic Medicine and $700 Million investment in Boston Seaport Site